balance equationreview2025-12-31
Difference 10000000 exceeds tolerance 9823000.000. Presentation or filing-vintage differences need review.
Revenue
$7.02B
Fiscal year ended 2025-12-31Operating income
Unavailable
Fiscal year ended 2025-12-31Free cash flow
$187.00M
Fiscal year ended 2025-12-31Xerox Holdings Corp (XRX) reported revenue of $7.02B and net income of -$1.03B for the fiscal year ended 2025-12-31. This page shows 9 annual periods of income statement, balance sheet and cash flow figures normalized from Xerox Holdings Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Computer Peripheral Equipment, NEC.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.02B | $6.22B | $6.89B | $7.11B | $7.04B | $7.02B | $9.07B | $117.00M | $9.99B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | $275.00M | $375.00M | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Net income | -$1.03B | -$1.32B | $1.00M | -$322.00M | -$455.00M | $192.00M | $1.35B | $361.00M | $195.00M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | Unavailable | Unavailable | Unavailable | Unavailable | shares 183.17M | shares 208.98M | shares 221.97M | shares 251.66M | shares 256.57M |
| Pretax income | Unavailable | Unavailable | Unavailable | -$328.00M | -$475.00M | $252.00M | $822.00M | $549.00M | $525.00M |
| Income tax expense | $541.00M | $105.00M | -$29.00M | -$3.00M | -$17.00M | $64.00M | $179.00M | $247.00M | $468.00M |
| Diluted EPS | $-8.25 | $-10.75 | $-0.09 | $-2.15 | $-2.56 | $0.84 | $5.80 | $1.38 | $0.71 |
| Selling, general & administrative | $1.65B | $1.54B | $1.70B | $1.76B | $1.72B | $1.85B | $2.08B | $2.38B | $2.51B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $512.00M | $576.00M | $519.00M | $1.04B | $1.84B | $2.62B | $2.74B | $1.08B | Unavailable |
| Total assets | $9.82B | $8.36B | $10.01B | $11.54B | $13.22B | $14.74B | $15.05B | $14.87B | Unavailable |
| Current assets | $3.57B | $2.94B | $3.18B | $4.11B | $4.70B | $5.78B | $6.14B | $4.71B | Unavailable |
| Total liabilities | $9.15B | $7.06B | $7.24B | $7.97B | $8.56B | $8.93B | $9.24B | $9.62B | Unavailable |
| Current liabilities | $3.22B | $2.62B | $2.78B | $3.33B | $2.83B | $2.48B | $3.44B | $3.25B | Unavailable |
| Total equity incl. NCI | $449.00M | $1.08B | $2.55B | $3.35B | $4.44B | $5.60B | $5.59B | $5.04B | $5.29B |
| Temporary (mezzanine) equity | $214.00M | $214.00M | $214.00M | $214.00M | $10.00M | $0 | $214.00M | $214.00M | Unavailable |
| Inventory | $1.02B | $695.00M | $661.00M | $797.00M | $696.00M | $843.00M | $694.00M | $829.00M | Unavailable |
| Accounts receivable | $1.12B | $796.00M | $850.00M | $857.00M | $818.00M | $883.00M | $1.24B | $1.27B | Unavailable |
| Goodwill | $2.22B | $1.94B | $2.75B | $2.82B | $3.29B | $4.07B | $3.90B | $3.86B | $3.92B |
| Long-term debt | $4.02B | $2.81B | $2.71B | $2.87B | $3.60B | $4.05B | $3.23B | $4.27B | Unavailable |
| Accounts payable | $1.50B | $1.02B | $1.04B | $1.33B | $1.07B | $983.00M | $1.05B | $1.07B | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $224.00M | $511.00M | $686.00M | $159.00M | $629.00M | $548.00M | $1.33B | $1.14B | -$267.00M |
| Capital expenditures | $37.00M | $27.00M | $29.00M | $36.00M | $29.00M | $44.00M | $41.00M | $55.00M | $69.00M |
| Investing cash flow | -$698.00M | -$198.00M | -$5.00M | -$78.00M | -$85.00M | -$246.00M | $2.15B | -$29.00M | $165.00M |
| Financing cash flow | $404.00M | -$271.00M | -$1.20B | -$822.00M | -$1.31B | -$416.00M | -$1.83B | -$1.30B | -$985.00M |
| Net change in cash | -$66.00M | $14.00M | -$522.00M | -$770.00M | -$782.00M | -$104.00M | $1.65B | -$220.00M | -$1.03B |
| Stock-based compensation | $45.00M | $52.00M | $54.00M | $75.00M | $54.00M | $42.00M | $50.00M | $57.00M | $52.00M |
| Common dividends paid | $57.00M | $127.00M | $151.00M | $160.00M | $192.00M | $216.00M | $229.00M | $255.00M | $274.00M |
| Common share repurchases | $0 | $8.00M | $544.00M | $113.00M | $888.00M | $300.00M | $600.00M | $700.00M | $0 |
| Depreciation & amortization | $331.00M | $274.00M | $251.00M | $270.00M | $327.00M | $368.00M | $430.00M | $526.00M | $527.00M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $187.00M | $484.00M | $657.00M | $123.00M | $600.00M | $504.00M | $1.29B | $1.08B | -$336.00M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | 5.3% | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| FCF margin | 2.7% | 7.8% | 9.5% | 1.7% | 8.5% | 7.2% | 14.3% | 927.4% | -3.4% |
| SBC / revenue | 0.6% | 0.8% | 0.8% | 1.1% | 0.8% | 0.6% | 0.6% | 48.7% | 0.5% |
| Current ratio | 1.11x | 1.12x | 1.14x | 1.23x | 1.66x | 2.33x | 1.79x | 1.45x | Unavailable |
| Revenue YoY growth | 12.9% | -9.7% | -3.1% | 1.0% | 0.2% | -22.5% | 7648.7% | -98.8% | Unavailable |
| Net margin | -14.7% | -21.2% | 0.0% | -4.5% | -6.5% | 2.7% | 14.9% | 308.5% | 2.0% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.5% | 0.4% | 0.4% | 0.5% | 0.4% | 0.6% | 0.5% | 47.0% | 0.7% |
| Long-term debt / equity | 8.94x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 25.4% | 21.8% | 45.0% | 89.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open XRX in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-17View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-12View SEC filing
Reconciliation checks needing review
4 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2024-12-31
Difference 10000000 exceeds tolerance 8365000.000. Presentation or filing-vintage differences need review.
balance equationreview2021-12-31
Difference 214000000 exceeds tolerance 13223000.000. Presentation or filing-vintage differences need review.
balance equationreview2020-12-31
Difference 214000000 exceeds tolerance 14741000.000. Presentation or filing-vintage differences need review.